Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III
Value in Health, 06/26/09
Stevenson M et al. - Bosentan is likely to be a more cost-effective first-line therapy for patients with PAH FC III in the UK than no active intervention.
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
2009 earnings survey: How do you compare
Medical Economics, 09/29/09
Physician pay cuts on horizon at Michigan Blues
American Medical News , 10/19/09
Medicare cracks down on false claims
Medical Economics, 11/02/09
Sponsor
Article Search
Sponsor